TY - JOUR T1 - Vasoproliferative retinal tumour JF - British Journal of Ophthalmology JO - Br J Ophthalmol SP - 399 LP - 400 DO - 10.1136/bjo.2005.086066 VL - 90 IS - 4 AU - B Damato Y1 - 2006/04/01 UR - http://bjo.bmj.com/content/90/4/399.abstract N2 - Brachytherapy requires further evaluation Vasoproliferative retinal tumour is an enigmatic disease, characterised by one or more retinal nodules, which are usually located pre-equatorially and inferotemporally, and which cause retinal exudates, macular oedema, and epiretinal membranes. Numerous single case reports and several case series have been published, with the disease described using a variety of terms.1–4 The tumour in question consists mostly of glial cells interlaced with a fine capillary network and dilated, hyalinised blood vessels, some of which are occluded.5–7 Exudates, macrophages, and foreign body giant cells are also present. The histology does not indicate a “vasoproliferative” tumour. The term “reactionary retinal glioangiosis” has been proposed.5 Approximately 75% of cases are idiopathic and 25% are secondary to other ocular diseases, such as retinitis pigmentosa, uveitis, retinal detachment, congenital toxoplasmosis, and Coats’ disease.3,8 Multiple lesions occur in about 6% of patients without predisposing disease … ER -